Dr. Lima will begin the session by giving an overview and update on biophysical methods, namely three-dimensional structural data and single-molecule imaging, that MSK uses to understand biological processes, decipher mechanisms, and discover new biology.
Join Us
Sloan Kettering Institute's Director’s Session
Hosted by Joan Massagué, PhD, Chief Scientific Officer, Director of the Sloan Kettering Institute (SKI), and Marie-Josée and Henry R. Kravis Chair; Scott Stuart, Chair of the MSK Board of Trustees; and Marie-Josée Kravis, Vice Chair of the MSK Board
Featured speakers
Christopher Lima, PhD
Chair of the Structural Biology Program at the Sloan Kettering Institue and Alfred P. Sloan Chair
Piro Lito, MD, PhD
Member of the Human Oncology and Pathogenesis Program at MSK and Enid A. Haupt Chair of Therapeutic Research
Structural Biology and Targeted Therapy
Dr. Lima will discuss the current state of the structural biology field. Dr. Lito will speak on the ways in which structural biology can guide drug development.
co_present
auto_graph
Dr. Lito will present on the ways structural biology has helped us better understand how cancer-causing mutations can lead to KRAS activation. He will also discuss how structural biology has accelerated the discovery of novel therapeutics for what is considered the Holy Grail of precision medicine.
Questions? Please contact us.
MSK Giving Events
mail_outline
mskgivingevents@mskcc.org